Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis

Objective To estimate the cost effectiveness of vaccinating people with high risk conditions against invasive pneumococcal disease using the 13 valent pneumococcal conjugate vaccine. Design Economic evaluation using a cohort model from the perspective of healthcare providers. Setting England. Partic...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Rozenbaum, Mark H, van Hoek, Albert Jan, Fleming, Douglas, Trotter, Caroline L, Miller, Elizabeth, Edmunds, W John
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group Ltd. 2012
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3482156/
https://ncbi.nlm.nih.gov/pubmed/23103369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.e6879
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires